These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 33887577)

  • 1. Neutrophil: An emerging player in the occurrence and progression of metabolic associated fatty liver disease.
    Chen S; Guo H; Xie M; Zhou C; Zheng M
    Int Immunopharmacol; 2021 Aug; 97():107609. PubMed ID: 33887577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophages in metabolic associated fatty liver disease.
    Alharthi J; Latchoumanin O; George J; Eslam M
    World J Gastroenterol; 2020 Apr; 26(16):1861-1878. PubMed ID: 32390698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic-associated fatty liver disease and lipoprotein metabolism.
    Heeren J; Scheja L
    Mol Metab; 2021 Aug; 50():101238. PubMed ID: 33892169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemcabene downregulates inflammatory, lipid-altering and cell-signaling genes in the STAM™ model of NASH.
    Oniciu DC; Hashiguchi T; Shibazaki Y; Bisgaier CL
    PLoS One; 2018; 13(5):e0194568. PubMed ID: 29847555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease.
    Katsarou A; Moustakas II; Pyrina I; Lembessis P; Koutsilieris M; Chatzigeorgiou A
    World J Gastroenterol; 2020 May; 26(17):1993-2011. PubMed ID: 32536770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisomal β-oxidation regulates whole body metabolism, inflammatory vigor, and pathogenesis of nonalcoholic fatty liver disease.
    Moreno-Fernandez ME; Giles DA; Stankiewicz TE; Sheridan R; Karns R; Cappelletti M; Lampe K; Mukherjee R; Sina C; Sallese A; Bridges JP; Hogan SP; Aronow BJ; Hoebe K; Divanovic S
    JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting Non-Alcoholic Fatty Liver Disease Progression and Immune Deregulations by Specific Gene Expression Patterns.
    Zeng F; Zhang Y; Han X; Zeng M; Gao Y; Weng J
    Front Immunol; 2020; 11():609900. PubMed ID: 33574818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of neutrophils in innate immunity-driven nonalcoholic steatohepatitis: lessons learned and future promise.
    Wu L; Gao X; Guo Q; Li J; Yao J; Yan K; Xu Y; Jiang X; Ye D; Guo J
    Hepatol Int; 2020 Sep; 14(5):652-666. PubMed ID: 32880077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis.
    Ma C; Kesarwala AH; Eggert T; Medina-Echeverz J; Kleiner DE; Jin P; Stroncek DF; Terabe M; Kapoor V; ElGindi M; Han M; Thornton AM; Zhang H; Egger M; Luo J; Felsher DW; McVicar DW; Weber A; Heikenwalder M; Greten TF
    Nature; 2016 Mar; 531(7593):253-7. PubMed ID: 26934227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptors and metabolic (dysfunction)-associated fatty liver disease.
    Khanmohammadi S; Kuchay MS
    Pharmacol Res; 2022 Nov; 185():106507. PubMed ID: 36252773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophages and scavenger receptors in obesity-associated non-alcoholic liver fatty disease (NAFLD).
    Kragh Petersen S; Bilkei-Gorzo O; Govaere O; Härtlova A
    Scand J Immunol; 2020 Nov; 92(5):e12971. PubMed ID: 32892401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil extracellular traps in patients with liver cirrhosis and hepatocellular carcinoma.
    Zenlander R; Havervall S; Magnusson M; Engstrand J; Ågren A; Thålin C; Stål P
    Sci Rep; 2021 Sep; 11(1):18025. PubMed ID: 34504150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear factor erythroid 2-related factor 2-mediated signaling and metabolic associated fatty liver disease.
    Bukke VN; Moola A; Serviddio G; Vendemiale G; Bellanti F
    World J Gastroenterol; 2022 Dec; 28(48):6909-6921. PubMed ID: 36632321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients.
    Chiappini F; Coilly A; Kadar H; Gual P; Tran A; Desterke C; Samuel D; Duclos-Vallée JC; Touboul D; Bertrand-Michel J; Brunelle A; Guettier C; Le Naour F
    Sci Rep; 2017 Apr; 7():46658. PubMed ID: 28436449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C.
    Tanwar S; Rhodes F; Srivastava A; Trembling PM; Rosenberg WM
    World J Gastroenterol; 2020 Jan; 26(2):109-133. PubMed ID: 31969775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy in nonalcoholic steatohepatitis.
    Amir M; Czaja MJ
    Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):159-66. PubMed ID: 21476911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging Roles of T Cells in the Pathogenesis of Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.
    Hirsova P; Bamidele AO; Wang H; Povero D; Revelo XS
    Front Endocrinol (Lausanne); 2021; 12():760860. PubMed ID: 34777255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in metabolic and liver pathobiology induced by two dietary mouse models of nonalcoholic fatty liver disease.
    Zhang H; Léveillé M; Courty E; Gunes A; N Nguyen B; Estall JL
    Am J Physiol Endocrinol Metab; 2020 Nov; 319(5):E863-E876. PubMed ID: 32924526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrogenic Pathways in Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD).
    Subramanian P; Hampe J; Tacke F; Chavakis T
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity.
    Shalapour S; Lin XJ; Bastian IN; Brain J; Burt AD; Aksenov AA; Vrbanac AF; Li W; Perkins A; Matsutani T; Zhong Z; Dhar D; Navas-Molina JA; Xu J; Loomba R; Downes M; Yu RT; Evans RM; Dorrestein PC; Knight R; Benner C; Anstee QM; Karin M
    Nature; 2017 Nov; 551(7680):340-345. PubMed ID: 29144460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.